M&A Deal Summary

IRIS International Acquires AlliedPath

On August 2, 2010, IRIS International acquired life science company AlliedPath for 5M USD

Acquisition Highlights
  • This is IRIS International’s 2nd transaction in the Life Science sector.
  • This is IRIS International’s largest (disclosed) transaction.
  • This is IRIS International’s 2nd transaction in the United States.
  • This is IRIS International’s 2nd transaction in California.

M&A Deal Summary
Date 2010-08-02
Target AlliedPath
Sector Life Science
Buyer(s) IRIS International
Deal Type Add-on Acquisition
Deal Value 5M USD

Target

AlliedPath

San Diego, California, United States
AlliedPath, Inc. is a high complexity CLIA-licensed laboratory offering a menu of high quality, solid tumor specific tests.

Search 198,242 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

IRIS International

Chatsworth, California, United States
Category Company
Founded 1979
Sector Medical Products
Employees387
DESCRIPTION

IRIS International, Inc. is a manufacturer of automated in-vitro diagnostics systems and consumable. Company focused on products that analyze particles and living cell forms and structures, or morphology of a variety of body fluids.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 2 of 2
State (California) 2 of 2
Country (United States) 2 of 2
Year (2010) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-04-04 Leucadia Technologies

Carlsbad, California, United States

Leucadia Technologies, Inc. is a biotechnology company.

Buy -
Mergr

Product

Company

Legal